ARN1468 is an orally active serpin inhibitor that inhibits serpin activity, thereby releasing proteases and further reducing prion accumulation; it exhibits anti-prion activity in ScGT1RML, ScGT122L, ScN2aRML, and ScN2a22L cell lines with EC50 values of 8.64, 19.3, 11.2, and 6.27 μM, respectively.